Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyPep-1 with or without pembrolizumab in advanced solid tumors
NCT04260529Phase 2Completed
- Sponsor
- Cytovation
- Start
- Apr 2020
- Primary completion
- Jul 2024
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of cypep-1 in malignant solid tumor, sponsored by Cytovation. Started Apr 2020; status: completed.
02
Drugs
cypep-1
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT04260529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04260529.